Evidence demonstrates that Sp1 modulates drug resistance of LSCs by regulating survivin expression [12], and that Sp1 drives DHX15 expression in acute lymphoblastic leukemia [13]. This evidence concerns the gene SP1 and acute lymphoblastic leukemia.